Evaluation of Cardioverter Capacity of Amiodarone Pre-electrical Cardioversion in Persistent Atrial Fibrillation
Condition(s) studied
Investigational drug(s) / intervention(s)
Amiodarone (Antiarrhythmic drug): Comparing 2 regimes of amiodarone pre-electrical cardioversion witn ECG monitoring
Study summary
Phase: IV Population: Sample size= 122 patients; male and female; ≥ 18 y.o.; patients with persistent atrial fibrillation referred for electrical cardioversion; performed in Spain Number of Sites: 4 Study Duration: 15/10/2024 - 15/5/2026 Subject Participation Duration: 2-4 months (depending on the arm) Description of Agent or Intervention: amiodarone
Objectives:
Primary: To compare the efficacy of amiodarone in pre-ECV reversal to sinus rhythm in a one-month impregnation regimen versus a 5-day regimen Secondary: 1) Identify days from initiation of pre-ECV amiodarone to reversion to SR using a mobile device paired to the mobile phone; 2) To compare the joint efficacy in the reversion to SR pre-ECV and in the maintenance of SR at 1 month after ECV of a one-month pre-ECV amiodarone impregnation regimen vs a 5-day regimen
Description of Study Design: Multicenter randomized open clinical trial. 122 Patients with persistent AF (≥7 days duration) electively referred for CVE will be included. Two amiodarone regimens administered pre-CVE will be compared evaluating their cardioverter efficacy. Patients will be randomized to 2 groups:
1. Treatment impregnation with amiodarone starting one month before ECV (600 mg/day 1st week, 400 mg/day 2nd week and 200 mg/day thereafter until ECV).
2. Treatment impregnation with amiodarone 800 mg/day started 5 days before ECV. Estimated Time to Complete Enrollment: 13 months
Eligibility
Primary outcome measure(s)
- Reversal to sinus rhythm pre-electrical cardioversion — From date of enrollment until the date of electrical cardioversion, up to 8 weeks
Number of patients who revert to sinus rhythm before electrical cardioversion
Trial sites (4)
| Facility | City | Region | Status |
|---|---|---|---|
| Hospital Universitari Germans Trias i Pujol | Badalona | Spain | |
| Hospital de la Santa Creu i Sant Pau | Barcelona | Spain | |
| Hospital Universitari de Sant Joan | Reus | Spain | |
| Hospital Clínico Universitario de Santiago | Santiago de Compostela | Spain |
More Institut Investigacio Sanitaria Pere Virgili trials in Spain
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06645249 on ClinicalTrials.gov ↗ ← All trials in Spain